EDGAR Filing Documents for 0000950170-23-070386

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0000950170-23-070386

Filing Date

2023-12-14

Accepted

2023-12-14 16:05:15

Documents

Period of Report

2023-12-12

Document Format Files

Seq	Description	Document	Type	Size
1	4	ownership.html	4
1	4	ownership.xml	4	4886
	Complete submission text file	0000950170-23-070386.txt		6330

Mailing Address C/O DECIPHERA PHARMACEUTICALS, INC. 200 SMITH STREET WALTHAM MA 02451

Business Address

Type: 4 | Act: 34 | File No.: 001-38219 | Film No.: 231487096

Mailing Address 200 SMITH STREET WALTHAM MA 02451

Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400

Deciphera Pharmaceuticals, Inc. (Issuer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations